Summary:
Click image to enlarge
Breathe
Easier. Join the Future of Asthma Care.
If you’ve been
living with moderate to severe asthma, you may be eligible
to participate in a clinical research study testing a potential new
treatment.
The purpose
of the study is to determine the safety and tolerability of a single dose
of the study drug and see how the study drug metabolizes in adult
subjects with moderate to severe asthma. The study is evaluating a long-acting investigational
medication that targets TSLP — a key driver of
airway inflammation in asthma.
Qualified Participants Must:
• Be 18–75 years old
•
Have a confirmed diagnosis of asthma for at least 12 months
•
Use a controller inhaler plus at least one other asthma medication
Smoking criteria: non-smokers
•
BMI: 18-40kg/m2
•
Health status is further evaluated by reviewing medical history, screening assessments, and visit with physician.
Qualified Participants May Receive:
- Subcutaneous (under-the-skin)
injections every 24 weeks
- Study duration: 48-week
treatment + follow-up
- Regular health monitoring by a
medical team
Compensation
may be available for time and travel.